LCM
PRTK

Laurion Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Laurion Capital Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,100
Closed -$254K – 1431
2017
Q3 		$254K Buy
+10,100
New +$254K ﹤0.01% 914
2017
Q2 		– Hold
0
– – – 1400
2017
Q1 		– Hold
0
– – – 1139